Huang, Yu http://orcid.org/0009-0000-7326-1920
Cheung, Carol Y
Li, Dawei
Tham, Yih Chung http://orcid.org/0000-0002-6752-797X
Sheng, Bin
Cheng, Ching Yu http://orcid.org/0000-0003-0655-885X
Wang, Ya Xing http://orcid.org/0000-0003-2749-7793
Wong, Tien Yin http://orcid.org/0000-0002-8448-1264
Funding for this research was provided by:
National Key Research and Development Program of China
Article History
Received: 2 July 2023
Revised: 26 July 2023
Accepted: 25 August 2023
First Online: 14 September 2023
Competing interests
: TYW is a consultant for Aldropika Therapeutics, Bayer, Boehringer-Ingelheim, Genentech, Iveric Bio, Novartis, Oxurion, Plano, Roche, Sanofi, Shanghai Henlius. He is an inventor, holds patents and is a co-founder of start-up companies EyRiS and Visre, which have interests in, and develop digital solutions for eye diseases.